Economic implications of newborn screening for cystic fibrosis: a cost of illness retrospective cohort study-Reference-Cited by-同舟云学术

Economic implications of newborn screening for cystic fibrosis: a cost of illness retrospective cohort study

Published:2007-04 Issue:9568 Volume:369 Page:1187-1195
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Sims Erika J,Mugford Miranda,Clark Allan,Aitken David,McCormick Jonathan,Mehta Gita,Mehta Anil

Publisher

Elsevier BV

Subject

General Medicine

Reference31 articles.

1. State-of-the-art for DNA technology in newborn screening;McCabe;Acta Paediatr Supp,1999

2. Analysis of the costs of diagnosing cystic fibrosis with a newborn screening program;Lee;J Pediatr,2003

3. Newborn screening for cystic fibrosis: a paradigm for public health genetics policy development: proceedings of a 1997 workshop;MMWR Recomm Rep,1997

4. Neonatal screening for inborn errors of metabolism: cost, yield and outcome;Pollitt;Health Technol Assess,1997

5. Nutritional benefits of neonatal screening for cystic fibrosis;Farrell;N Engl J Med,1997

Cited by 78 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Direct healthcare costs in the first 2 years of life: A comparison of screened and clinically diagnosed children with cystic fibrosis – The Irish comparative outcomes study of CF (ICOS);Journal of Cystic Fibrosis;2024-07

2. Die Goldenen Zwanziger der Mukoviszidose;CME;2023-12

3. Decision-Making About Newborn Screening Panels in Canada: Risk Management and Public Participation;Democratizing Risk Governance;2023

4. Healthcare resource utilisation and medical costs for children with interstitial lung diseases (chILD) in Europe;Thorax;2022-02-11

5. The Changing Face of Cystic Fibrosis: An Update for Anesthesiologists;Anesthesia & Analgesia;2022-01-12